SCHEMBL13767940

SCHEMBL13767940

Cc1ccc(NC(=O)CC(OC(C)(C)C(C)(C)C(=O)C(C)OC(C)(C)C)C(=O)C(C)(C)C)c(S(=O)(=O)O)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.35
GAA P10253 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 3/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 2/20 0.32
BRD4 O60885 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
LPAR1 Q92633 1/20 0.31
NLRP3 Q96P20 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13844226 0.92 KMT2A (0.33) KMT2AGAALMNAMAPTHSD17B10
SCHEMBL14035565 0.90 KMT2A (0.35) KMT2AGAALMNAMAPTHSD17B10
SCHEMBL13844133 0.89 ALDH1A1 (0.36) LMNAMAPTALDH1A1HTTMAPK1
SCHEMBL13768015 0.87 CA1 (0.37) GAAHSD17B10ALDH1A1SMN1; SMN2HTT
SCHEMBL13767997 0.81 CD40 (0.39)
SCHEMBL14035564 0.80 CA1 (0.39) LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL13768116 0.80 CYP1A2 (0.33) GAALMNAALDH1A1CYP1A2CYP2C19
SCHEMBL14273521 0.79 CASR (0.41) KMT2ALMNAALDH1A1SMN1; SMN2HTT
SCHEMBL13768301 0.78 KDM4E (0.36) GAAHSD17B10ALDH1A1CYP1A2CYP2C19
SCHEMBL13844188 0.77 POLB (0.38) LMNAHSD17B10ALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557176-B2 Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor CANON KABUSHIKI KAISHA (JP) 2009-07-07 US disclosed
EP-1774410-B1 CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS CANON KK (JP) 2008-11-19 EP disclosed
US-20080064828-A1 Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor CANON KABUSHIKI KAISHA (JP) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064828-A1 Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor FAR1, ACSL4, ACAD11 KMT2A 2171/4885GAA 1982/4885LMNA 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.